Net Cash Provided by (Used in) Operating Activities |
-760K |
USD |
+80.9% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
2.02M |
USD |
|
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Common Stock, Shares, Issued |
39.8M |
shares |
+88.6% |
Q2 2023 |
Q2 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.28M |
USD |
|
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
362K |
USD |
-68.7% |
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Valuation Allowance |
12.7M |
USD |
+47.7% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Gross |
12.7M |
USD |
+47.7% |
Q4 2022 |
FY 2022 |
Depreciation |
334 |
USD |
-42.6% |
Q2 2023 |
Q2 2023 |
Payments to Acquire Property, Plant, and Equipment |
1.55K |
USD |
|
Q1 2022 |
Q1 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-8.65M |
USD |
+45.4% |
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2022 |
FY 2022 |
Additional Paid in Capital |
48.6M |
USD |
+6.31% |
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Share-based Payment Arrangement, Expense |
318K |
USD |
-35% |
Q2 2023 |
Q2 2023 |
Interest Expense |
0 |
USD |
-100% |
Q4 2022 |
Q4 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |